Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of a travelers' diarrhea vaccine system in travelers to India.
Steffen R, Cramer JP, Burchard G, Jelinek T, Schwarz U, Ramdas P, Chatterjee S, Jiang ZD, DuPont HL, Dewasthaly S, Westritschnig K, Behrens RH. Steffen R, et al. Among authors: dewasthaly s. J Travel Med. 2013 Nov-Dec;20(6):374-9. doi: 10.1111/jtm.12064. Epub 2013 Aug 26. J Travel Med. 2013. PMID: 24165382 Free article. Clinical Trial.
Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.
Behrens RH, Cramer JP, Jelinek T, Shaw H, von Sonnenburg F, Wilbraham D, Weinke T, Bell DJ, Asturias E, Pauwells HL, Maxwell R, Paredes-Paredes M, Glenn GM, Dewasthaly S, Stablein DM, Jiang ZD, DuPont HL. Behrens RH, et al. Among authors: dewasthaly s. Lancet Infect Dis. 2014 Mar;14(3):197-204. doi: 10.1016/S1473-3099(13)70297-4. Epub 2013 Nov 29. Lancet Infect Dis. 2014. PMID: 24291168 Clinical Trial.
Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trial.
Lazarus R, Querton B, Corbic Ramljak I, Dewasthaly S, Jaramillo JC, Dubischar K, Krammer M, Weisova P, Hochreiter R, Eder-Lingelbach S, Taucher C, Finn A; Valneva phase 3 trial group. Lazarus R, et al. Among authors: dewasthaly s. Lancet Infect Dis. 2022 Dec;22(12):1716-1727. doi: 10.1016/S1473-3099(22)00502-3. Epub 2022 Sep 5. Lancet Infect Dis. 2022. PMID: 36075233 Free PMC article. Clinical Trial.
Immunological fingerprinting of group B streptococci: from circulating human antibodies to protective antigens.
Meinke AL, Senn BM, Visram Z, Henics TZ, Minh DB, Schüler W, Neubauer C, Gelbmann D, Noiges B, Sinzinger J, Hanner M, Dewasthaly S, Lundberg U, Hordnes K, Masoud H, Sevelda P, von Gabain A, Nagy E. Meinke AL, et al. Among authors: dewasthaly s. Vaccine. 2010 Oct 8;28(43):6997-7008. doi: 10.1016/j.vaccine.2010.08.041. Epub 2010 Aug 21. Vaccine. 2010. PMID: 20732466
11 results